ISPOR 2023 Home
  • About
    • News Center
  • Award Winners
  • Program
    • Program
    • Learning Formats
    • Posters
    • Program Committee
    • Educational Symposia
    • Exhibit Hall Theaters
    • Plenaries
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsor List
    • Exhibitor Directory
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2023

May 7-10, 2023

  • Home
  • Events
  • Past Conferences
  • ISPOR 2023
  • Program
  • Program
  • Session

  • Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

    May 10, 2023, 09:30 AM
  • «
  • 421
  • 422
  • 423
  • 424
  • 425
  • 426
  • 427
  • 428 (current)
  • 429
  • 430
  • »
Quick Links
  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal
  • Antitrust Compliance
  • Code of Ethics
  • Cookie Policy
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Terms and Conditions

Subscribe

Join ISPOR

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group